Biotechnology Fundraising Reflects Bigger Start-Ups, Fewer IPOs in 2005

Fundraising among private biotechs has evened out this year, with larger early rounds reflecting the renewed "think-big" strategy of some start ups, and larger late rounds a consequence of less receptive IPO markets.